Iridex (IRIX) Interest & Investment Income (2010 - 2011)

Iridex (IRIX) posted quarterly Interest & Investment Income of -$247000.0 for Q4 2011, down 88.55% quarter-over-quarter from -$131000.0 in Q4 2011.

Iridex (IRIX) Interest & Investment Income (2010 - 2011) Analysis & Trends

Iridex's Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$247000.0 for Q4 2011.

In Q4 2011, Interest & Investment Income changed N/A year-over-year to -$247000.0; the TTM figure through Dec 2011 stood at -$468000.0 (changed N/A YoY), while the FY2026 annual figure was $324000.0, changed N/A from the prior year.
Interest & Investment Income for Q4 2011 stood at -$247000.0, down from -$131000.0 in the prior quarter.
The five-year high for Interest & Investment Income was $63000.0 in Q4 2010, with the low at -$247000.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Abbott Laboratories	200.50 Bn	194.89 Bn	7.27 Bn	52.00 Mn
2	Stryker	130.00 Bn	126.52 Bn	4.50 Bn	-
3	Medtronic	120.36 Bn	111.14 Bn	6.41 Bn	-
4	Boston Scientific	74.19 Bn	73.65 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.73 Bn	48.48 Bn	1.35 Bn	30.00 Mn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.13 Bn	32.02 Bn	2.18 Bn	-
8	Koninklijke Philips	26.52 Bn	23.20 Bn	4.55 Bn	73.23 Mn
9	Steris	23.23 Bn	22.75 Bn	684.20 Mn	-
10	Iridex	13.00 Mn	8.32 Mn	4.30 Mn	-

Download Data